Aspen Pharmacare Holdings Limited

APNHYOTCHealthcare● Active

$9.03

+$0.16(+1.80%)

Market Cap$4.0B

P/E Ratio—

52W High$9.03

52W Low$5.24

Avg Volume185

Open$9.03

Beta0.35

Net Income Financials Revenue

Aspen Pharmacare Holdings Limited (APNHY) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

APNHY · net income · updated Jun 8, 2026

Core profitability metrics

APNHY · net income · margin · TTM · CAGR

Net income was −$1.08B for FY2025 (fiscal year ending 2025-06-30), down 124.6% year-over-year. Net profit margin was -2.5%. Based on available data, Aspen Pharmacare Holdings Limited has been profitable since at least 2011.

FY2025 Net Income−$1.08B▼ -124.6% YoY

Trailing 12M (TTM)$2.41Btrailing 4 quarters sum

Net Profit Margin-2.5%−$1.08B ÷ $43.36B

YoY Change-124.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · APNHY net income history · APNHY profit margin

Annual net income data

APNHY · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$1.08B▼ 124.6%-2.5%$43.36B

FY2024$4.40B▼ 15.8%9.8%$44.71B

FY2023$5.23B▼ 19.4%12.8%$40.71B

FY2022$6.49B▲ +35.0%16.8%$38.61B

FY2021$4.81B▲ +3.0%12.7%$37.77B

Net income vs peers (Healthcare)

APNHY vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Aspen Pharmacare Holdings LimitedYOU

APNHY

−$1.08B-124.6%-2.5%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Aspen Pharmacare Holdings Limited (APNHY) reported net income of −$1.08B for FY2025 (fiscal year ending 2025-06-30), down 124.6% year-over-year. The net profit margin was -2.5% — meaning the company kept $-0.03 of every dollar of revenue as profit.

Based on available data, Aspen Pharmacare Holdings Limited has been profitable since at least 2011. Net income reached a peak of $6.49B in FY2022. Data available for 15 fiscal years.

Aspen Pharmacare Holdings Limited's net profit margin was -2.5% for FY2025, based on the latest annual results.

Investors sometimes search for "Aspen Pharmacare Holdings Limited net worth" — the company's market capitalization is a separate figure from APNHY net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

APNHY net income · 5 questions

Aspen Pharmacare Holdings Limited is not currently profitable on an annual basis. The company reported a net loss of $1.08B for FY2025.

is APNHY profitabledoes APNHY make a profitAPNHY profitabilityAPNHY profitable company

▸ Source: FMP /income-statement · GAAP · Aspen Pharmacare Holdings Limited · Aspen Pharmacare Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026